MetLife, Inc. MET | NYSE

$81.36 $1.25 | 1.56%

After Hours
$81.33 -$0.03 | -0.04%

Next Earnings: Jan 29, 2025

Company Overview:

Market Cap: $56.34B
PE Ratio: 16.5
52-Week Range: $64.61 - $89.05
Dividend Yield (FWD): 2.68% ($2.18)

10 Year Performance Metrics:

Total Return (with DRIP): 136.57% (8.99% / yr)
Total Return (no DRIP): 105.28% (7.46% / yr)
Share Price: 68.94%
Dividend Increase: 74.71%
MET 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

MET Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
MET Dividend CAGR:1Y: 4.81%2Y: 4.40%5Y: 4.37%10Y: 5.74%
Share Price
MET Price CAGR:1Y: 24.75%2Y: 6.46%5Y: 9.64%10Y: 5.43%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

MET Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - MET
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - MET
14-Day FREE Trial Get Full Access Now!

MET Earnings, Revenue, Cash & Debt, Shares Outstaning:

MET - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
MET - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
MET - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
MET - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
MET - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
MET - Cash & Debt
14-Day FREE Trial Get Full Access Now!
MET - Revenue
14-Day FREE Trial Get Full Access Now!
MET Revenue CAGR:1Y: 16.22%2Y: -9.03%5Y: -0.26%10Y: -0.11%
MET - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
MET EPS CAGR:1Y: 223.21%2Y: 92.19%5Y: -4.93%10Y: 1.05%
MET - Net Income
14-Day FREE Trial Get Full Access Now!
MET Net Income CAGR:1Y: 174.44%2Y: 84.32%5Y: -9.28%10Y: -4.35%
MET - EBITDA
14-Day FREE Trial Get Full Access Now!
MET EBITDA CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
MET - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
MET Free Cash Flow CAGR:1Y: 6.95%2Y: -1.28%5Y: 7.05%10Y: 6.12%
MET - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
MET Free Cash Flow / Share CAGR:1Y: 14.92%2Y: 5.31%5Y: 13.32%10Y: 11.29%
MET - Gross Profit
14-Day FREE Trial Get Full Access Now!
MET Gross Profit CAGR:1Y: 16.22%2Y: -9.03%5Y: -0.26%10Y: -0.11%
MET - Expenses
14-Day FREE Trial Get Full Access Now!
MET Expenses CAGR:1Y: -100.00%2Y: N/A5Y: -100.00%10Y: -100.00%
MET - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
MET Shares Outstanding CAGR:1Y: -6.86%2Y: -6.25%5Y: -5.55%10Y: -4.72%
MET - Share Buybacks
14-Day FREE Trial Get Full Access Now!
MET Share Buybacks CAGR:1Y: -2.27%2Y: 7.16%5Y: -0.28%10Y: 5.83%
MET - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
MET Stock-Based Comp CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
MET - Dividends
14-Day FREE Trial Get Full Access Now!
MET Dividend CAGR:1Y: 4.81%2Y: 4.40%5Y: 4.37%10Y: 5.74%
MET - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
MET Revenue CAGR:1Y: 16.22%2Y: -9.03%5Y: -0.26%10Y: -0.11%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MET - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MET Actual Revenue CAGR:1Y: 16.22%2Y: -9.03%5Y: -0.26%10Y: -0.11%
MET - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MET Actual EPS CAGR:1Y: 223.21%2Y: 92.19%5Y: -4.93%10Y: 1.05%
MET - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MET Actual Net Income CAGR:1Y: 174.44%2Y: 84.32%5Y: -9.28%10Y: -4.35%
MET - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
MET Actual EBITDA CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%

Ratios, Profit Margins & Return on Capital:

MET - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
MET Net Profit Margin CAGR:1Y: 136.36%2Y: 102.81%5Y: -9.04%10Y: -3.08%
MET - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
MET Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MET - Price to Earnings
14-Day FREE Trial Get Full Access Now!
MET - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
MET - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
MET - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

MET Dividends Info:

Annual Dividend: $2.18
Forward Yield: 2.68%
Ex-Dividend Date: 2024-11-05
Lifetime Dividens / Share: $25.69

MET Dividend History: Dates, Payments & Yield list

Below is a schedule of all MET dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/05/202412/16/2024$0.5452.76%2.79%$78.15
08/06/202409/10/2024$0.5453.11%3.18%$68.60
05/06/202406/11/2024$0.5452.96%3.06%$71.19
02/05/202403/14/2024$0.5203.16%3.16%$65.81
11/08/202312/14/2023$0.5203.47%3.5%$59.35
08/07/202309/14/2023$0.5203.18%3.24%$64.18
05/08/202306/14/2023$0.5203.76%3.87%$53.69
02/06/202303/14/2023$0.5002.85%2.85%$70.09
11/07/202212/14/2022$0.5002.68%2.71%$73.93
08/08/202209/14/2022$0.5003.11%3.18%$62.94
05/09/202206/14/2022$0.5002.96%3.05%$65.64
02/07/202203/14/2022$0.4802.79%2.79%$68.87
11/08/202112/14/2021$0.4802.98%3.01%$63.74
08/09/202109/14/2021$0.4803.11%3.18%$60.46
05/10/202106/14/2021$0.4802.8%2.89%$66.47
02/04/202103/15/2021$0.4603.55%3.55%$51.90
11/02/202012/14/2020$0.4604.7%4.75%$38.70
08/03/202009/14/2020$0.4604.83%4.93%$37.30
05/07/202006/12/2020$0.4605.17%5.34%$34.44
02/03/202003/13/2020$0.4403.54%3.54%$49.69
11/04/201912/13/2019$0.4403.66%3.7%$47.59
08/05/201909/13/2019$0.4403.77%3.86%$45.57
05/06/201906/13/2019$0.4403.57%3.7%$47.59
02/04/201903/13/2019$0.4203.72%3.72%$45.16
11/05/201812/13/2018$0.4203.72%3.77%$44.59
08/03/201809/13/2018$0.4203.62%3.71%$45.33
05/04/201806/13/2018$0.4203.41%3.63%$46.23
02/02/201803/13/2018$0.4003.18%3.36%$47.56
11/03/201712/13/2017$0.4002.69%2.93%$54.63
08/03/201709/13/2017$0.3572.99%2.99%$47.68
05/04/201706/13/2017$0.3573.04%3.04%$46.93
02/02/201703/13/2017$0.3573.11%3.11%$45.86
11/03/201612/13/2016$0.3573.35%3.4%$41.94
08/04/201609/13/2016$0.3573.92%4.05%$35.24
05/05/201606/13/2016$0.3573.56%3.74%$38.16
02/03/201603/14/2016$0.3343.58%3.58%$37.39
11/04/201512/11/2015$0.3342.92%2.97%$45.00
08/05/201509/11/2015$0.3342.61%2.7%$49.47
05/07/201506/12/2015$0.3342.74%2.88%$46.41
02/04/201503/13/2015$0.3122.87%2.87%$43.47
11/05/201412/12/2014$0.3122.43%2.57%$48.52
08/06/201409/12/2014$0.3122.44%2.73%$45.75
05/07/201406/13/2014$0.3122.35%2.79%$44.65
02/04/201403/13/2014$0.2452.3%2.3%$42.58
11/06/201312/13/2013$0.2452.11%2.29%$42.75
08/07/201309/13/2013$0.2452.98%2.22%$44.12
05/07/201306/13/2013$0.2452.94%2.7%$36.35
02/04/201303/13/2013$0.1652.48%1.99%$33.18
11/07/201212/14/2012$0.6602.27%9.08%$29.05
11/07/201112/14/2011$0.6602.19%8.75%$30.16
11/05/201012/14/2010$0.6601.76%7.03%$37.52
11/05/200912/14/2009$0.6604.38%8.76%$30.13
11/06/200812/15/2008$0.6602.3%9.18%$28.73
11/02/200712/14/2007$0.6601.16%4.63%$57.03
11/02/200612/15/2006$0.5261.94%4.13%$50.89
11/03/200512/15/2005$0.4631.04%4.17%$44.48
11/03/200412/13/2004$0.4101.8%4.81%$34.10
11/05/200312/15/2003$0.2051.42%2.96%$27.69
11/06/200212/13/2002$0.1870.79%3.15%$23.73
11/02/200112/14/2001$0.1781.48%2.95%$24.17
11/03/200012/15/2000$0.1780.76%3.03%$23.51

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for MET

Based on past 10-year performance, here are MET growth metrics:

Share price CAGR of +5.38%
Dividend CAGR of +5.74%
Using MET CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

MET
Current Price$81.36
Start Shares122.91
Start Value$10,000
 
After 10 years:
Final Share Count161.19
Dividends Payment$0.95
Annual Dividends$614
Yield on cost6.14%
Share Price$130.43
Total Dividends$4,040
Final Value$21,023

Estimated Future Value + Dividends - MET

NOTE: Above numbers are our estimate based on MET's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

MetLife, Inc. (MET) had its IPO on 2000-04-05, and is trader on NYSE stock exchange.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

MET website: https://www.metlife.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial